San Francisco, 5
November 2018: The global breast lesion localization methods market is expected to reach USD 1.57 billion by 2025, according
to a new report by Grand View Research, Inc. The increasing government and
non-government reimbursement policies for mammary gland cancer diagnosis,
biopsy, pre-surgical examinations, and other treatment options is estimated to
increase the adoption of breast lesion localization procedures. For instance,
the Alabama Breast and Cervical Cancer Early Detection Program aims to provide
breast and cervical oncology diagnostic and screening services to women who
meet certain income, age, and insurance coverage eligibility guidelines.
Furthermore, rising
prevalence of breast cancer is anticipated to propel the market growth. The
disease is highly prevalent amongst women belonging to the age group of 65
years or above. The maximum risk of mammary gland cancer is between the age of
70 and 79. On the other hand, men are also at a risk of breast cancer. In the
U.S., median age of men at diagnosis is approximately 68 years.
Access Research Report of Breast Lesion Localization
Methods Market@ www.grandviewresearch.com/industry-analysis/breast-lesion-localization-methods-market
Further key findings from the report suggest:
· Wire localization biopsy dominated the
market in 2016 owing to its higher usage by healthcare practitioners, easy
availability, and presence of a wide product range
· Magnetic tracer is expected to grow at
lucrative CAGR of 14.0% over the forecast period as a result of increasing
adoption of MagSNOLL technology over conventional wire localization.
· Radioisotope seed localization is
considered the most preferred method amongst all radioisotope localization
methods due to its benefits such as ease of localization few weeks before the
excision surgery and lesser need for reoperation.
· North America is estimated to be the
largest regional market. It dominated the market in terms of revenue with USD
185.04 million in 2016 owing to the presence of well-established healthcare
services and increasing number of oncology surgeries being performed.
· In addition, early adoption of devices and
shift from traditional to technologically advanced products by healthcare
providers are some of the factors anticipated to increase the demand for
localization devices in this region
· Asia Pacific is expected to be the fastest
growing region over the next decade with lucrative CAGR from 2017 to 2025 due
to growing awareness about breast screening among the people. Furthermore,
presence of a large target population and rising disposable income are some of
the factors expected to propel the growth of this region.
· Key players in this industry are Cianna
Medical, Inc.; Cook Medical; STERYLAB; CP Medical; SOMATEX Medical
Technologies; Argon Medical Devices, Inc.; and C.R BARD, Inc.
· Most of the key players are focusing on
strategies such as expansion of their product portfolios and collaborations,
mergers, & acquisitions. In November 2015, C.R. BARD, Inc. announced the
acquisition of Liberator Medical Holdings, Inc., a direct-to-customer
distributor of medical products.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/healthcare
Grand View Research has
segmented the global breast lesion localization methods market on the basis of
type and region:
Breast Lesion Localization Methods Type Outlook (Revenue,
USD Million, 2014 - 2025)
·
Wire Localization biopsy
·
Radioisotope localization
o
Radio-guided occult lesion localization
o
Radioactive seed localization
o
Others
·
Magnetic tracer
·
Others
Breast Lesion Localization Methods Regional Outlook
(Volume, Tons; Revenue, USD Million, 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
Breast Lesion Localization Methods Market@ www.grandviewresearch.com/press-release/global-breast-lesion-localization-methods-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment